participant_id,age_reported,gender,race,cohort,study_time_collected,study_time_collected_unit,virus,value_preferred
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187908.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,
SUB187909.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187910.1276,18.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187911.1276,32.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187912.1276,26,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,11.5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187913.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187914.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187915.1276,23.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,9.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,10.5
SUB187916.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,2.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187917.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,2.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187918.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187919.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187920.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,8.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187921.1276,21.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187922.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,9.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187923.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187924.1276,22.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,9
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187925.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187926.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187927.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187928.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6.5
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187929.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187930.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,10
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187931.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187932.1276,27.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187933.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,13
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4
SUB187934.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187935.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187936.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187937.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187938.1276,25,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187939.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187940.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187941.1276,19.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,9
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187942.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187943.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187944.1276,21.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187945.1276,20.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6.5
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187946.1276,23.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,10
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,7.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,10.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB187947.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187948.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187949.1276,21.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187950.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187951.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187952.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9.5
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,10
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187953.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187954.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187955.1276,20.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB187956.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9
SUB187957.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,11.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB187958.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9.5
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187959.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187960.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187961.1276,19.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,9
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187962.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187963.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187964.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187965.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,
SUB187966.1276,27.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187967.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187968.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187969.1276,26.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,9.5
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187970.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187971.1276,22.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,10.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187972.1276,20.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,3.5
SUB187973.1276,19.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187974.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187975.1276,21.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187976.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187977.1276,21.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187978.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187979.1276,24.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB187980.1276,18.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB187981.1276,22.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9
SUB187982.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,11.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB187983.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,10.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187984.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9.5
SUB187985.1276,21.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,
SUB187986.1276,18.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187987.1276,18.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB187988.1276,25.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187989.1276,18.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187990.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB187991.1276,18.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,3.5
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187992.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,3.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB187993.1276,20.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB187994.1276,20.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8.5
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4
SUB187995.1276,20.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,3.5
SUB187996.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB187997.1276,22.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11.5
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB187998.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB187999.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188000.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188001.1276,20.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,11
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,3.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,3.5
SUB188002.1276,19.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188003.1276,21,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB188004.1276,24.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,11.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188005.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188006.1276,19.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188007.1276,22.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188008.1276,23.1,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188009.1276,18.2,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188010.1276,22.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,9.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,8.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,2.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4
SUB188011.1276,25.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11.5
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188012.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188013.1276,21.8,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,9
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4
SUB188014.1276,24.6,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,6
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188015.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,10.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188016.1276,21.9,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,10.5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB188017.1276,20.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,11
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,11
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,10.5
SUB188018.1276,20.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12.5
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188019.1276,22.3,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,7
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,9
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,12.5
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9.5
SUB188020.1276,21.7,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,12.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,10.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188021.1276,22.4,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188022.1276,28.5,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,7.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,10
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,9.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188023.1276,22,Male,Not Specified,Discovery Cohort; Males  2008?2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188024.1276,25.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188025.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188026.1276,24.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188027.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188028.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188029.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188030.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188031.1276,20.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188032.1276,30.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188033.1276,26,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,10
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188034.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188035.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188036.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188037.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188038.1276,24.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188039.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188040.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188041.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188042.1276,31.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9.5
SUB188043.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188044.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188045.1276,22.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188046.1276,19.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188047.1276,22.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188048.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,
SUB188049.1276,40.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188050.1276,38.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188051.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188052.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188053.1276,20.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188054.1276,24.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188055.1276,20.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188056.1276,23.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188057.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188058.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188059.1276,34.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188060.1276,24.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,10.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188061.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188062.1276,21.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188063.1276,19.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9.5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188064.1276,21.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188065.1276,26.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188066.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,2.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188067.1276,19.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188068.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,3.5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188069.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,
SUB188070.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188071.1276,20.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188072.1276,19.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188073.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188074.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188075.1276,24.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,8.5
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188076.1276,27.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188077.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188078.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188079.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188080.1276,21.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188081.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188082.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188083.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,12
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,12
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,12
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188084.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,8.5
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,10
SUB188085.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,6.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188086.1276,20.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188087.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188088.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,8.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,7.5
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188089.1276,21.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188090.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,1.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188091.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188092.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,3.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,4.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188093.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9
SUB188094.1276,23.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188095.1276,27.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB188096.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8
SUB188097.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188098.1276,22.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188099.1276,20.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9
SUB188100.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188101.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188102.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188103.1276,29.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,8.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,8.5
SUB188104.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188105.1276,22.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188106.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,2.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188107.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,5.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7
SUB188108.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188109.1276,18.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188110.1276,19.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188111.1276,19.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,1.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,4.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188112.1276,22.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6.5
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,11
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,7.5
SUB188113.1276,19.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188114.1276,18.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188115.1276,21.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188116.1276,20.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188117.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6.5
SUB188118.1276,21.1,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188119.1276,22.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,5.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188120.1276,30.6,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6.5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188121.1276,19.8,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6.5
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188122.1276,24.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,4.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,4.5
SUB188123.1276,21,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188124.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188125.1276,28.5,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,6
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,7.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,7.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,9.5
SUB188126.1276,20.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,3
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,2.5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188127.1276,22.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,6
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,1.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,3.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,6
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,5.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188128.1276,19.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,2.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,9
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188129.1276,23.3,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,9
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3.5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,3.5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,4.5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4.5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5
SUB188130.1276,21.2,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,4.5
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,2.5
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,2.5
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,7
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,6
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,6
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,6
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,6
SUB188131.1276,23.9,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,5.5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,5.5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7.5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,3.5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188132.1276,20.4,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,7
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,B/Florida/4/2006,3
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/59/2007,4.5
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,0,Days,A/Brisbane/10/2007,7
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,B/Florida/4/2006,4
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/59/2007,5.5
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,14,Days,A/Brisbane/10/2007,8.5
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,B/Florida/4/2006,4.5
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/59/2007,5.5
SUB188133.1276,28.7,Female,Not Specified,Validation Cohort; Females 2008-2009 trivalent influenza vaccine,28,Days,A/Brisbane/10/2007,8
